Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: Researchers find promising candidate to treat irreversible lung and eye diseases in extremely premature infants
Released: 12-Dec-2023 6:05 AM EST
Researchers find promising candidate to treat irreversible lung and eye diseases in extremely premature infants
Elsevier

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.

Released: 9-Dec-2023 10:05 AM EST
Major breakthrough for severe asthma treatment
King's College London

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects.

Newswise: A dynamic picture of how we respond to high or low oxygen levels
Released: 9-Dec-2023 9:30 AM EST
A dynamic picture of how we respond to high or low oxygen levels
Gladstone Institutes

It only takes holding your breath for slightly too long to understand that too little oxygen is bad for you.

Newswise: The Medical Minute: Five home remedies can soothe your sore throat
Released: 7-Dec-2023 8:05 AM EST
The Medical Minute: Five home remedies can soothe your sore throat
Penn State Health

What can you do about that ache in your throat when you have a cold? A Penn State Heath family physician offers five remedies.

Newswise: A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
4-Dec-2023 11:05 AM EST
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC). And in an early parallel study in humans, combining immunotherapy with dupilumab—an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma—boosted patients' immune systems, with one out of the six experiencing significant tumor reduction. The findings were described in the December 6 issue of Nature.

Newswise: Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
Released: 6-Dec-2023 7:05 AM EST
Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
University of Missouri, Columbia

For 30 years, Cheryl Rosenfeld has studied how biological information gets transferred from mothers to babies during pregnancy.

Released: 5-Dec-2023 2:05 PM EST
Using AI to Speed — and Equalize — Medical Imaging
The Fannie and John Hertz Foundation

Hertz Fellow Sarah Hooper is developing solutions to reduce diagnostic imaging costs and address shortages and delays in radiology.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Significant
Released: 18-Nov-2023 1:05 PM EST
Significant "post-COVID" resurgence in invasive meningococcal disease
Institut Pasteur

A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic.

Newswise: First human clinical trial for pill-sized device that monitors breathing from the gut
Released: 18-Nov-2023 1:05 PM EST
First human clinical trial for pill-sized device that monitors breathing from the gut
Cell Press

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.

Newswise: Survey finds many Americans are letting their guard down during respiratory illness season
Released: 13-Nov-2023 9:05 AM EST
Survey finds many Americans are letting their guard down during respiratory illness season
Ohio State University Wexner Medical Center

Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.

Released: 13-Nov-2023 9:00 AM EST
Neurent Medical Announces New CPT Code® for Chronic Rhinitis Treatment Offering Significant Symptom Improvements
Neurent Medical

Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced a significant milestone for the chronic rhinitis market.

Released: 10-Nov-2023 8:00 AM EST
Urgent Need for Increased Global Access to Effective Prevention and Treatment of Pneumonia
American Thoracic Society (ATS)

On World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is highlighting the urgent challenges in pneumonia prevention and treatment globally.

Newswise: UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
Released: 9-Nov-2023 4:05 PM EST
UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
University of Texas Health Science Center at Houston

A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Newswise: Eliminating Mold After Natural Disasters is Vital for Those with Mold Allergy
3-Nov-2023 8:00 AM EDT
Eliminating Mold After Natural Disasters is Vital for Those with Mold Allergy
American College of Allergy, Asthma and Immunology (ACAAI)

Two new studies being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. show the harmful health effects of excess mold on those with asthma, while also discussing methods for getting rid of mold and other airborne allergens in the most efficient way possible.

Released: 8-Nov-2023 3:05 PM EST
Low-dose CT screening can catch lung cancer early - but most people overlook it
University of California, Los Angeles (UCLA), Health Sciences

November marks Lung Cancer Awareness Month and UCLA Health lung cancer experts are working to spread the word about the importance of low-dose computed tomography (LDCT) of the chest. The annual scan is recommended for people with a long-term history of smoking, as well as other criteria, including age.

Newswise: American College of Surgeons Supports National Lung Cancer Screening Day, Urges More Americans to Get Screened
Released: 8-Nov-2023 9:00 AM EST
American College of Surgeons Supports National Lung Cancer Screening Day, Urges More Americans to Get Screened
American College of Surgeons (ACS)

The American College of Surgeons (ACS) urges more Americans to take advantage of life-saving lung cancer screening.

Newswise: Systemic Sclerosis-associated Interstitial Lung Disease Focus of Latest Clinical Practice Guideline
Released: 8-Nov-2023 8:00 AM EST
Systemic Sclerosis-associated Interstitial Lung Disease Focus of Latest Clinical Practice Guideline
American Thoracic Society (ATS)

In patients with systemic sclerosis (SSc), a rare connective tissue disease, interstitial lung disease contributes to 35 percent of deaths. Published recently in the American Journal of Respiratory and Critical Care Medicine, the latest American Thoracic Society Clinical Practice Guideline makes a number of recommendations. One recommendation expands antifibrotic treatment to all patients with systemic sclerosis associated with ILD (SSc-ILD), not just those with progressive disease. Watch the explainer video.

Released: 7-Nov-2023 6:05 PM EST
Suspected bronchiectasis associated with higher risk of mortality in smokers
Brigham and Women’s Hospital

Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD).

Released: 7-Nov-2023 11:05 AM EST
Risk of dying in hospital from respiratory causes is higher in the summer than in the winter
Barcelona Institute for Global Health, ISGlobal

A study analyzes the association between ambient temperature and hospital mortality from respiratory diseases in the provinces of Madrid and Barcelona

31-Oct-2023 11:05 AM EDT
Lung Cancer Screening Dramatically Increases Long-term Survival Rate
Mount Sinai Health System

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves its cure rate measured over a 20-year period, according to a large-scale international study by Mount Sinai researchers published in Radiology.

6-Nov-2023 1:05 PM EST
New strategy may halt tumors' aggressive response to glucose deprivation
University of California, Los Angeles (UCLA), Health Sciences

Researchers found that by restricting glucose in lung cancer cells, it caused the cells to lose their specialized features, making them more aggressive. This change was linked to alteration in certain molecules and how they modify DNA structure.

Released: 6-Nov-2023 10:05 AM EST
Nasal microorganism to the rescue? Study confirms protective role of bacterium in chronic rhinosinusitis
University of Fukui

Scientists investigate how microbes in the nasal mucosa may influence the pathophysiology of chronic sinusitis

Released: 2-Nov-2023 5:05 PM EDT
November is Lung Cancer Awareness Month; Indiana University experts available for interviews
Indiana University

November is Lung Cancer Awareness Month. Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s scientists, physician-scientists, and staff are available to offer expertise in treatment innovations, the biology of lung cancers, research initiatives, and tips for smoking cessation.

Newswise: American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
30-Oct-2023 12:05 PM EDT
American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
American Cancer Society (ACS)

The American Cancer Society releasesan update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.

Newswise: Life-Changing Treatment for COPD Now Offered at Hackensack University Medical Center
Released: 30-Oct-2023 3:05 PM EDT
Life-Changing Treatment for COPD Now Offered at Hackensack University Medical Center
Hackensack Meridian Health

November is COPD Awareness Month, a recognition dedicated to raising awareness about Chronic Obstructive Pulmonary Disease (COPD), its impact on individuals and communities & the latest treatment options.

Newswise: UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome
Released: 26-Oct-2023 11:05 AM EDT
UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome
University of Texas Health Science Center at Houston

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Released: 25-Oct-2023 9:30 AM EDT
Rutgers Awarded NIH Grant to Study How Previous Infections Affect Immune Response to Lung Disease
Rutgers University-New Brunswick

Researchers will examine how the body’s adaptations to viruses, fungi and parasites change its ability to combat unrelated respiratory infections.

Released: 24-Oct-2023 1:35 PM EDT
From nanoplastics to airborne toxins: Pollution stories for media.
Newswise

Read the latest research news on air pollution, nanoplastics, waterborne illnesses and more in the Pollution channel on Newswise.

       
Released: 24-Oct-2023 1:05 PM EDT
Lung Cancer Awareness Month: Progress in early screening and diagnostics, plus smoking cessation programs to help reduce health disparities
Fred Hutchinson Cancer Center

As Lung Cancer Awareness Month begins in November, experts at Fred Hutchinson Cancer Center remain committed to advancing early screening, helping people quit smoking and developing new ways to detect and treat lung cancer.

Released: 24-Oct-2023 11:05 AM EDT
Preventing airborne infection without impeding communication with ions and electric field
Tokyo Institute of Technology

Researchers in Tokyo developed a device using ions and an electric field to capture infectious droplets and aerosols, allowing communication while preventing airborne infection

Released: 23-Oct-2023 5:05 PM EDT
How long should kids isolate after they’ve contracted COVID-19?
University of Southern California (USC)

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

Released: 20-Oct-2023 5:05 PM EDT
How cord-like aggregates of bacteria lead to tuberculosis infections
Cell Press

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago.

Released: 20-Oct-2023 11:00 AM EDT
Oral steroid usage increased across U.S., Taiwan and Denmark in past decade
Michigan Medicine - University of Michigan

Commonly used to treat acute respiratory infections, the amount being prescribed is on the rise

Released: 19-Oct-2023 12:05 PM EDT
Tobacco purchases rise following restrictions on e-cigarette sales, study finds
Yale University

E-cigarette flavor bans may drive people to smoke cigarettes instead, study finds

Released: 19-Oct-2023 8:00 AM EDT
Share Your Research with the Respiratory Disease Community at ATS 2024 in San Diego
American Thoracic Society (ATS)

The American Thoracic Society is accepting scientific abstracts and case report submissions for presentation at the ATS 2024 International Conference in San Diego, May 17-22. Submissions on all aspects of respiratory disease, critical care medicine and sleep medicine will be considered and are due no later than Wednesday, Nov. 1, 2023, at 5 p.m. ET.

Newswise: Therapeutic nanocarriers reduce lung inflammation in mice
Released: 19-Oct-2023 3:20 AM EDT
Therapeutic nanocarriers reduce lung inflammation in mice
National Institute of Biomedical Imaging and Bioengineering

There is no cure or FDA-approved therapy for acute respiratory distress syndrome, which has a high rate of mortality. Inflammation plays a major role in developing ARDS. Researchers at Ohio State University developed therapeutic nanocarriers using mice skin cells, which reduced inflammation in their lungs.

   
Newswise: News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Released: 17-Oct-2023 10:00 AM EDT
News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Johns Hopkins Medicine

The United States’ respiratory virus season — which typically lasts from October to April — is making its annual return. The flu, COVID-19, respiratory syncytial virus (RSV) infection and other respiratory illnesses tend to circulate more in the fall and winter months, which can lead to a surge in hospitalizations.

Released: 16-Oct-2023 11:05 AM EDT
Moffitt Research Finds Non-Small Cell Lung Cancer Drug Lorlatinib Targets Additional Protein
Moffitt Cancer Center

In a new study published in Cell Chemical Biology, Moffitt Cancer Center researchers demonstrate this, showing that the ROS1 inhibitor lorlatinib has activity against an additional protein called PYK2. The team also reveals the mechanisms of this inhibition.

16-Oct-2023 9:05 AM EDT
Viral Persistence and Serotonin Reduction Can Cause Long COVID Symptoms, Penn Medicine Research Finds
Perelman School of Medicine at the University of Pennsylvania

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

Newswise:Video Embedded navigating-childhood-asthma-insights-from-a-pediatric-pulmonologist
VIDEO
Released: 12-Oct-2023 11:05 PM EDT
Navigating Childhood Asthma: Insights From a Pediatric Pulmonologist
Cedars-Sinai

As the seasons transition from warm fall nights to cool and wintry evenings, children with asthma often experience a rise in wheezing or chest tightness, because weather changes and cold temperatures are often asthma triggers.

Released: 9-Oct-2023 6:05 PM EDT
Should a more individualized model replace the current method for determining which people should be screened for lung cancer?
Wiley

A new study found that an alternative model to identify patients with lung cancer eligible for screening was more accurate than the currently used method based on the United States Preventive Services Task Force (USPSTF) criteria.

Released: 9-Oct-2023 6:05 AM EDT
Clinical trial reveals benefits of inhaled nitric oxide for patients with respiratory failure due to COVID-19 pneumonia
Massachusetts General Hospital

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.

Released: 9-Oct-2023 3:05 AM EDT
Scientists discover ‘long colds’ may exist, as well as long Covid
Queen Mary University of London

A new study from Queen Mary University of London, published in The Lancet’s EClinicalMedicine, has found that people may experience long-term symptoms —or ‘long colds’—after acute respiratory infections that test negative for COVID-19.

Released: 6-Oct-2023 7:05 AM EDT
Wastewater surveillance research provides a 12-day lead time for RSV season: new study
University of Ottawa

In a first-of-its-kind study, researchers using wastewater surveillance over conventional indicators have predicted the start of the annual respiratory syncytial virus (RSV) season 12 days early.

28-Sep-2023 12:55 PM EDT
Artificial intelligence helps to simplify lung cancer risk prediction
University College London

Machine learning models to identify the simplest way to screen for lung cancer have been developed by researchers from UCL and the University of Cambridge, bringing personalised screening one step closer.

Newswise: Computer model predicts who needs lung cancer screening
26-Sep-2023 12:05 PM EDT
Computer model predicts who needs lung cancer screening
PLOS

A machine learning model equipped with only data on people’s age, smoking duration and the number of cigarettes smoked per day can predict lung cancer risk and identify who needs lung cancer screening, according to a new study publishing October 3rd in the open access journal PLOS Medicine by Thomas Callender of University College London, UK, and colleagues.



close
1.59372